Penserra Capital Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,092
Closed -$596K 1102
2025
Q1
$596K Buy
40,092
+7,120
+22% +$109K 0.01% 564
2024
Q4
$491K Buy
32,972
+17,409
+112% +$284K 0.01% 572
2024
Q3
$297K Buy
+15,563
New +$323K 0.01% 639
2023
Q4
Sell
-3,794
Closed -$65K 1330
2023
Q3
$65K Buy
3,794
+2,152
+131% +$44.9K ﹤0.01% 956
2023
Q2
$34K Buy
+1,642
New +$35.7K ﹤0.01% 1052

Other funds holding OGN

Penserra Capital Management's OGN Position: Q2 2025 in Review

Penserra Capital Management sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 40,092 shares — an estimated $596K sold.

Penserra Capital Management first reported a position in OGN in Q2 2023 and held it in 5 quarters. The position peaked at $596K in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Penserra Capital Management reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Penserra Capital Management sold 40,092 Organon & Co shares in Q2 2025, an estimated $596K.
  • Penserra Capital Management first reported a position in Organon & Co in Q2 2023 and held it in 5 quarters.
  • Penserra Capital Management's Organon & Co position peaked at $596K in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Penserra Capital Management's 13F filing for Q2 2025, filed 6 Aug 2025.